These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17194)

  • 1. Characterization of the suppressor cell generated in a murine graft-versus-host reaction (GVHR).
    Shand FL
    Transplant Proc; 1977 Mar; 9(1):277-9. PubMed ID: 17194
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of graft-versus-host-reaction (GVHR) by in vitro incubation of donor lymphocytes with thymic or splenic chalone (s).
    Kiger N; Florentin I; Garcia-Giralt E; Mathé G
    Exp Hematol; 1973; 1(1):22-8. PubMed ID: 4153630
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM; Rimm AA; Saltzstein EC; Rodey GE
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 11. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Status of T- and B-lymphocytes in long living CBA--F1 (CBA X C57BL/6) chimeras].
    Cherniakhovskaia IIu; Nesterenko VG; Filitis LN; Fontalin LN; Novikova TK
    Biull Eksp Biol Med; 1978 Aug; 86(8):197-200. PubMed ID: 28802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-host-induced immunosuppression. The effect of antigenic stimulation on cell-mediated and humoral immune responses.
    Treiber W; Lapp WS
    Transplantation; 1973 Sep; 16(3):211-6. PubMed ID: 4147031
    [No Abstract]   [Full Text] [Related]  

  • 15. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):634-6. PubMed ID: 234788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras.
    Shih CC; Truitt RL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2664-7. PubMed ID: 2950639
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological studies of NK cell-deficient beige mice. I. Defective ability of beige lymphocytes to mediate local and systemic graft-versus-host reactions.
    Baca ME; Mowat AM
    Immunology; 1989 Jan; 66(1):125-30. PubMed ID: 15493274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of graft versus host reactivity by a single host-specific blood transfusion to prospective donors of hemopoietic cells.
    Knulst AC; Bril-Bazuin C; Ruizeveld de Winter JA; Benner R
    Transplant Proc; 1990 Aug; 22(4):1975-6. PubMed ID: 2389502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.